We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 6,232 results
  1. IL20RB signaling enhances stemness and chemotherapy resistance in pancreatic cancer

    Objective

    Pancreatic cancer is an aggressive malignancy with high mortality, and cancer cell stemness and related drug resistance are considered...

    **ao-hui Li, Gui-zhong Huang, ... **ao-jun Lin in Journal of Translational Medicine
    Article Open access 14 December 2023
  2. Cuproptosis engages in c-Myc-mediated breast cancer stemness

    Background

    Intra-tumoral heterogeneity (ITH) is a distinguished hallmark of cancer, and cancer stem cells (CSCs) contribute to this malignant...

    Runtian Wang, Kun Xu, ... **aoxiang Guan in Journal of Translational Medicine
    Article Open access 23 June 2023
  3. Integrative multi-omics analysis unveils stemness-associated molecular subtypes in prostate cancer and pan-cancer: prognostic and therapeutic significance

    Background

    Prostate cancer (PCA) is the fifth leading cause of cancer-related deaths worldwide, with limited treatment options in the advanced stages....

    Kun Zheng, Youlong Hai, ... Jie Hao in Journal of Translational Medicine
    Article Open access 07 November 2023
  4. Pancreatic cancer stemness: dynamic status in malignant progression

    Pancreatic cancer (PC) is one of the most aggressive malignancies worldwide. Increasing evidence suggests that the capacity for self-renewal,...

    Yutong Zhao, Cheng Qin, ... Weibin Wang in Journal of Experimental & Clinical Cancer Research
    Article Open access 13 May 2023
  5. LncRNA H19 Participates in Leukemia Inhibitory Factor Mediated Stemness Promotion in Colorectal Cancer Cells

    Colorectal cancer (CRC) is a common human malignancy and the third leading cause of cancer-related death worldwide. Cancer stem cells (CSCs) were...

    Min Zhu, Ruihong Yu, ... Boyu Du in Biochemical Genetics
    Article 10 January 2024
  6. Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer

    Background

    Ropivacaine, a local anesthetic, exhibits anti-tumor effects in various cancer types. However, its specific functions and the molecular...

    Lin Ding, Hui Jiang, ... Yong Zhu in Journal of Experimental & Clinical Cancer Research
    Article Open access 25 March 2024
  7. Rab11-FIP4 interacts with ARF5 to promote cancer stemness in hepatocellular carcinoma

    Recent studies suggest that Rab11-family interacting proteins (Rab11-FIPs) play an important role in tumorigenesis and progression. Among the...

    Feifeng Song, Qi Zhang, ... ** Huang in Journal of Physiology and Biochemistry
    Article 17 July 2023
  8. Low-density lipoprotein receptor promotes crosstalk between cell stemness and tumor immune microenvironment in breast cancer: a large data-based multi-omics study

    Background

    Tumor cells with stemness in breast cancer might facilitate the immune microenvironment’s suppression process and led to anti-tumor immune...

    Qihang Yuan, **aona Lu, ... Mengying Tong in Journal of Translational Medicine
    Article Open access 30 November 2023
  9. DRP1 inhibition-mediated mitochondrial elongation abolishes cancer stemness, enhances glutaminolysis, and drives ferroptosis in oral squamous cell carcinoma

    Background

    Mitochondrial dynamics play a fundamental role in determining stem cell fate. However, the underlying mechanisms of mitochondrial dynamics...

    Zhen Wang, Shouyi Tang, ... Qianming Chen in British Journal of Cancer
    Article 06 April 2024
  10. Knockdown of SETD5 Inhibits Colorectal Cancer Cell Growth and Stemness by Regulating PI3K/AKT/mTOR Pathway

    SET domain-containing 5 (SETD5), a member of protein lysine methyltransferase family, is expressed in multiple cancers, making it potential...

    **aohua Zhou, Wenqiang Chen, ... Hongqing Rui in Biochemical Genetics
    Article 19 April 2024
  11. Targeted silencing of SOCS1 by DNMT1 promotes stemness of human liver cancer stem-like cells

    Background

    Human liver cancer stem-like cells (HLCSLCs) are widely acknowledged as significant factors in the recurrence and eradication of...

    Lei Lou, Tingyun Deng, ... **ang Li in Cancer Cell International
    Article Open access 12 June 2024
  12. The BET degrader ZBC260 suppresses stemness and tumorigenesis and promotes differentiation in triple-negative breast cancer by disrupting inflammatory signaling

    Background

    Breast cancer stem cells (BCSCs) are resistant to standard therapies, facilitate tumor dissemination, and contribute to relapse and...

    Deeksha Sharma, Cody G. Hager, ... Monika L. Burness in Breast Cancer Research
    Article Open access 15 November 2023
  13. LINC00853 contributes to tumor stemness of gastric cancer through FOXP3-mediated transcription of PDZK1IP1

    Background

    The incidence and mortality of gastric cancer (GC) are high worldwide. Tumor stemness is a major contributor to tumorigenesis and...

    **a Hu, Maoyuan Zhao, ... **hao Zeng in Biological Procedures Online
    Article Open access 04 July 2023
  14. TRIM58 downregulation maintains stemness via MYH9-GRK3-YAP axis activation in triple-negative breast cancer stem cells

    TRIM58 is a member of the TRIM protein family, which possess with E3 ubiquitin ligase activities. Studies have revealed that low expression of TRIM58...

    Xujun Li, **g Jiang, ... Fan Yang in Cancer Gene Therapy
    Article 07 May 2024
  15. m6A-modified circABCC4 promotes stemness and metastasis of prostate cancer by recruiting IGF2BP2 to increase stability of CCAR1

    Prostate cancer (PCa) is a malignant tumor of the urinary system. CircABCC4 has been demonstrated to promote the development of PCa; however, its...

    Changkun Huang, Ran Xu, ... Hongyi Jiang in Cancer Gene Therapy
    Article 10 August 2023
  16. LITAF inhibits colorectal cancer stemness and metastatic behavior by regulating FOXO1-mediated SIRT1 expression

    Lipopolysaccharide-induced tumor necrosis factor alpha factor (LITAF) is a transcription factor that activates the transcription of TNF-α and...

    Jiao Guan, Zheng-Yun Zhang, ... Lei Qin in Clinical & Experimental Metastasis
    Article 02 June 2023
  17. Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity

    Background

    Pancreatic ductal adenocarcinoma (PDAC) is a profoundly aggressive and fatal cancer. One of the key factors defining its aggressiveness and...

    Quan Zheng, Jiajia Tang, ... Christopher Heeschen in Journal of Experimental & Clinical Cancer Research
    Article Open access 28 November 2023
  18. Fbxw7 suppresses carcinogenesis and stemness in triple-negative breast cancer through CHD4 degradation and Wnt/β-catenin pathway inhibition

    Background

    Cancer stem cells (CSCs) are a small population of cells in tumor tissues that can drive tumor initiation and promote tumor progression. A...

    Guodong ** Lu, ... Huijie Fan in Journal of Translational Medicine
    Article Open access 24 January 2024
  19. U2AF2-SNORA68 promotes triple-negative breast cancer stemness through the translocation of RPL23 from nucleoplasm to nucleolus and c-Myc expression

    Background

    Small nucleolar RNAs (snoRNAs) play key roles in ribosome biosynthesis. However, the mechanism by which snoRNAs regulate cancer stemness...

    Wenrong Zhang, **nyue Song, ... Ang Zheng in Breast Cancer Research
    Article Open access 09 April 2024
  20. BCL7B, a SWI/SNF complex subunit, orchestrates cancer immunity and stemness

    Cancer is one of the main causes of human death. Here, we focus on the B-cell lymphoma 7 protein family member B (BCL7B) gene, an accessory subunit...

    Sayaka Higuchi, Yuji Suehiro, ... Shohei Mitani in BMC Cancer
    Article Open access 30 August 2023
Did you find what you were looking for? Share feedback.